Clinical Trial Update: Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for the malaria treatment dihydroartemisinin-piperaquine in children (MIC-DroP); the study is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Dihydroartemisinin-piperaquine (dihydroartemisinin-piperaquine)

Snippet

Sponsor: Grant Dorsey, M.D, Ph.D. | Conditions: Malaria | Phase 3 | Status: ACTIVE_NOT_RECRUITING